
Tenet Healthcare Corp
THCNYSECIK 70318HealthcareFiscal year ends Dec 31
Reports and events: 401 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2017-09-0121:23 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-17-274592 |
| 2017-08-3117:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-17-274456 |
| 2017-08-1816:05 ET | SC 13D/A | Ownership report, active investor, amended | 0000905148-17-000756 |
| 2017-08-1806:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-17-261572 |
| 2017-08-1116:27 ET | 8-K/A | 5.07 Shareholder vote results | 0000070318-17-000014 |
| 2017-08-0717:10 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0000070318-17-000012 |
| 2017-08-0716:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000070318-17-000010 |
| 2017-08-0216:59 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000070318-17-000006 |
| 2017-08-0108:16 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000070318-17-000004 |
| 2017-07-1717:03 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-17-007069 |
| 2017-06-1616:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-17-206046 |
| 2017-06-0621:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-17-195026 |
| 2017-06-0508:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-17-193745 |
| 2017-05-0516:26 ET | 8-K | 5.07 Shareholder vote results | 0001193125-17-160866 |
| 2017-05-0116:39 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001558370-17-003181 |
| 2017-05-0116:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-151912 |
| 2017-03-2421:53 ET | DEF 14A | Proxy statementPeriod 2017-05-04 | 0001193125-17-094187 |
| 2017-02-2716:44 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001558370-17-001079 |
| 2017-02-2716:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-058987 |
| 2016-12-0116:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-16-782572 |
| 2016-11-1719:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-16-770013 |
| 2016-11-1608:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-16-769384 |
| 2016-11-0409:08 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-16-759632 |
| 2016-10-3116:36 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001558370-16-008902 |
| 2016-10-3116:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-16-753550 |
| 2016-10-0310:26 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-16-728855 |
| 2016-09-1616:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-16-712302 |
| 2016-08-0117:27 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001558370-16-007064 |
| 2016-08-0117:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-16-666812 |
| 2016-05-1316:26 ET | 8-K | 5.07 Shareholder vote results | 0001193125-16-590440 |
| 2016-05-0216:35 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001558370-16-005116 |
| 2016-05-0216:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-16-572646 |
| 2016-04-0108:04 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-16-526898 |
| 2016-03-3118:11 ET | DEF 14A | Proxy statementPeriod 2016-05-12 | 0001193125-16-524071 |
| 2016-03-2216:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-16-513450 |
| 2016-03-0909:11 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-16-497632 |
| 2016-02-2217:19 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001558370-16-003350 |
| 2016-02-2216:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-16-471728 |
| 2016-02-0116:46 ET | SC 13D/A | Ownership report, active investor, amended | 0000905148-16-001187 |
| 2016-01-1908:02 ET | SC 13D | Ownership report, active investor | 0001140361-16-047979 |
| 2016-01-1906:12 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-431613 |
| 2016-01-1517:10 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-16-431204 |
| 2016-01-1211:47 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-16-427594 |
| 2015-12-0917:13 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-15-399011 |
| 2015-12-0109:19 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-15-391393 |
| 2015-11-0216:42 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001558370-15-002120 |
| 2015-11-0216:26 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-15-362369 |
| 2015-10-2321:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-15-351076 |
| 2015-08-0316:54 ET | 10-Q | Quarterly reportPeriod 2015-06-30 | 0001558370-15-001335 |
| 2015-08-0316:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-15-274866 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 02:42 ET. Listed shows no prices and gives no investment advice.